文献速递肾癌与肾肿瘤

改良5G技术机器人辅助腹腔镜远程手术在泌尿外科的应用

Application of Improved Robot-assisted Laparoscopic Telesurgery with 5G Technology in Urology.
PubMed 文献 · Eur Urol · 2022-07-09

2021年3月至10月,青岛一家三级医院的外科医生通过5G技术远程控制手术机器人,为8家基层医院的29例患者实施机器人辅助腹腔镜根治性肾切除术,中位往返延迟26毫秒,中位距离187公里。结果表明5G技术与手术机器人结合是肾肿瘤远程医疗的一种新型潜在治疗选择,患者总结认为该技术安全可行,远程端与手术室总延迟仅200毫秒。

要点

  • 2021年3月至10月,29例患者经5G远程机器人辅助腹腔镜根治性肾切除术,未中转其他手术且无主要术中术后并发症。
  • 中位往返延迟26毫秒(四分位距5),中位距离187公里(四分位距57)。
  • 患者总结认为5G远程手术是肾肿瘤安全可行的治疗选择,总延迟仅200毫秒。

核心结论

  • 5G技术与手术机器人结合是肾肿瘤远程医疗的一种新型潜在治疗选择。
  • 患者总结指出,使用5G技术的远程手术是肾肿瘤患者安全可行的治疗选择。

研究设计与样本

  • 2021年3月至10月,青岛一家三级医院的外科医生使用 surgeon-controlled 手术机器人,为8家基层医院的29例患者远程实施机器人辅助腹腔镜根治性肾切除术(RN)。
  • 主从单元均由网络和机械工程师保障,患者端手术助手做好充分准备以预防并发症。
  • 主要评价指标为成功率,定义为未中转其他手术且无主要术中或术后并发症的成功远程RN患者百分比。

主要发现

  • 中位往返延迟为26毫秒(四分位距5),基层医院与外科医生之间的中位距离为187公里(四分位距57)。
  • 远程端与手术室之间的总延迟仅为200毫秒。

关键数值与推荐

  • 主要评价指标成功率定义为未中转其他手术且无主要术中或术后并发症的成功远程RN患者百分比。
  • 中位往返延迟26毫秒(四分位距5),中位距离187公里(四分位距57),总延迟200毫秒。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The demand for telesurgery is rising rapidly, but robust evidence regarding the feasibility of its application in urology is still rare. From March to October 2021, a surgeon-controlled surgical robot in a tertiary hospital in Qingdao was used to remotely conduct robot-assisted laparoscopic radical nephrectomy (RN) in 29 patients located in eight primary hospitals. The median round-trip delay was 26 ms (interquartile range [IQR] 5) and the median distance between the primary hospital and the surgeon was 187 km (IQR 57). Both the master unit and the slave unit were guaranteed by network and mechanical engineers, and surgical assistants were well prepared on the patient side to prevent complications. The primary evaluation metric was the success rate, defined as the percentage of patients who underwent successful remote RN without conversion to other surgical procedures and no major intraoperative or postoperative complications. The results demonstrate that the combination of 5G technology and surgical robots is a novel potential telemedicine-based therapy choice for renal tumors. PATIENT SUMMARY: Our study shows that telesurgery using 5G technology is a safe and feasible treatment option for patients with kidney tumors. The total delay between the remote location and the operating rooms where surgery was being performed was just 200 ms. This approach could reduce health care costs and improve the quality of medical services accessed by patients.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Li J, Yang X, Chu G, et al. Application of Improved Robot-assisted Laparoscopic Telesurgery with 5G Technology in Urology. Eur Urol. 2022. PMID: 35817641. doi:10.1016/j.eururo.2022.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。